452 related articles for article (PubMed ID: 33178018)
1. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma.
Schnipper J; Dhennin-Duthille I; Ahidouch A; Ouadid-Ahidouch H
Front Pharmacol; 2020; 11():568993. PubMed ID: 33178018
[TBL] [Abstract][Full Text] [Related]
2. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.
Hofschröer V; Najder K; Rugi M; Bouazzi R; Cozzolino M; Arcangeli A; Panyi G; Schwab A
Front Pharmacol; 2020; 11():586599. PubMed ID: 33841132
[TBL] [Abstract][Full Text] [Related]
3. Transportome Malfunctions and the Hallmarks of Pancreatic Cancer.
Ling Q; Kalthoff H
Rev Physiol Biochem Pharmacol; 2021; 181():105-127. PubMed ID: 32770395
[TBL] [Abstract][Full Text] [Related]
4. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
[TBL] [Abstract][Full Text] [Related]
5. Ca
Bettaieb L; Brulé M; Chomy A; Diedro M; Fruit M; Happernegg E; Heni L; Horochowska A; Housseini M; Klouyovo K; Laratte A; Leroy A; Lewandowski P; Louvieaux J; Moitié A; Tellier R; Titah S; Vanauberg D; Woesteland F; Prevarskaya N; Lehen'kyi V
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205590
[TBL] [Abstract][Full Text] [Related]
6. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic K
Soret B; Hense J; Lüdtke S; Thale I; Schwab A; Düfer M
Biol Chem; 2023 Mar; 404(4):339-353. PubMed ID: 36571487
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer.
Sauter DR; Sørensen CE; Rapedius M; Brüggemann A; Novak I
Biochim Biophys Acta; 2016 Oct; 1862(10):1994-2003. PubMed ID: 27443495
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
[TBL] [Abstract][Full Text] [Related]
11. Ion channels in control of pancreatic stellate cell migration.
Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
[TBL] [Abstract][Full Text] [Related]
12. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
13. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
14. Challenges in Diagnosis and Treatment of Pancreatic Exocrine Insufficiency among Patients with Pancreatic Ductal Adenocarcinoma.
Lan X; Robin G; Kasnik J; Wong G; Abdel-Rahman O
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831673
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
[TBL] [Abstract][Full Text] [Related]
16. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior.
Miknyoczki SJ; Lang D; Huang L; Klein-Szanto AJ; Dionne CA; Ruggeri BA
Int J Cancer; 1999 May; 81(3):417-27. PubMed ID: 10209957
[TBL] [Abstract][Full Text] [Related]
19. Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis.
Yee NS; Kazi AA; Li Q; Yang Z; Berg A; Yee RK
Biol Open; 2015 Mar; 4(4):507-14. PubMed ID: 25770184
[TBL] [Abstract][Full Text] [Related]
20. TADG-12 as an early marker in the development of pancreatic ductal adenocarcinoma (PDAC): involvement of insulin containing cells.
Amsterdam A; Raanan C; Shpigner L; Shwiqi A; Melzer E; Schreiber L
Acta Histochem; 2014 Jun; 116(5):781-7. PubMed ID: 24560937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
